Navigation Links
Advanced Health Media Acquires Advogent
Date:2/2/2010

BRIDGEWATER, N.J., Feb. 2 /PRNewswire/ -- Advanced Health Media, LLC (AHM), the leading U.S. provider of pharmaceutical sales, marketing and compliance technology and services, announced it has acquired substantially all of the assets of Advogent Group, Inc. (Advogent), a Piscataway, NJ-based provider of marketing services for the pharmaceutical industry. Integration of the companies will begin immediately and headquarters will remain at AHM's Bridgewater, N.J. office. Terms of the agreement were not disclosed.

The addition of Advogent's services and customers expands AHM's market presence and leadership and provides a foundation for ongoing business growth, while offering pharmaceutical industry customers the broadest possible suite of marketing and relationship management services that comply with all federal and state regulations. "This acquisition solidifies AHM's market leadership position in speaker bureau management and marketing communications," said Kevin McMurtry, Founder and CEO of Advanced Health Media. "The combined business will be one of the largest marketing services and technology suppliers in the pharmaceutical industry. Our scale and breadth of services will be a competitive advantage for AHM and its customers."

"We are excited about the integration of these two organizations," said Jeff Brady, President of AHM.  "AHM and Advogent have each established proven track records for exceptional service to their customers.  Our expanded organization has the scale and experience needed to provide our clients the highest levels of service in an increasingly complex promotional environment."  

About Advanced Health Media, LLC

Advanced Health Media (AHM) is the leading U.S. provider of speaker-led meeting logistics, state and federal regulatory compliance technology, thought leader development and medical communications. AHM offers a fully integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, customer relationship management and compliance tracking and reporting systems.  AHM also provides full-service medical communications, including strategic communication strategy, publication planning, scientific meetings and key opinion leader advocacy development. AHM provides services to more than 50 companies in the pharmaceutical sector.

Headquartered in Bridgewater, NJ, with offices in Union and Somerville, NJ, Chesapeake, VA, and Chicago, IL, AHM is the parent company of AHM Solutions, Centeon Solutions, Embryon, LLC, Cogenix, LLC, ProMedix, LLC, InsiteResearch, LLC and Ephikacy, LLC. For more information, please visit the AHM Web site at www.ahmdirect.com.

About Advogent Group, Inc.

Advogent Group, Inc. creates, delivers, and manages compliant communications and strategic solutions and services for pharmaceutical, biotechnology, and medical device companies. The company offers strategic publication services; and healthcare communications, including advocacy development and management, message delivery and management, and content creation. It also provides event management and logistics, and compliant data systems. The company was founded in 2007 and is headquartered in Piscataway, New Jersey. Advogent Group, Inc. is a former subsidiary of Cardinal Health, Inc.

SOURCE Advanced Health Media, LLC

RELATED LINKS
http://www.ahmdirect.com

'/>"/>

SOURCE Advanced Health Media, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Inc. ("Hill-Rom") (NYSE: HRC ) today ... ended March 31, 2017, and raised its outlook ... guidance reflect the contribution from the Mortara Instrument ... 14, 2017.  For the fiscal second ... share compared to $0.33 per diluted share in ...
(Date:4/26/2017)... Phoenix Marketing Solutions ( Phoenix ) ... mission of transforming science into clinical practice. During a time ... innovative approach supports the life sciences industry by ... in science and medicine — which ultimately improves lives. ... 2002 by Tracy Doyle and Angela Fiordilino ...
(Date:4/25/2017)... Endo International plc (NASDAQ: ENDP ) will announce its ... management team will host a conference call and webcast before the ... The dial-in number to access the call is U.S./ Canada ... 6086379. Please dial in 10 minutes prior to the scheduled start ... call will be available from May 9, 2017 at 11:30 a.m. ...
Breaking Medicine Technology:
(Date:4/30/2017)... ... April 30, 2017 , ... ... the importance of substantially reducing melanoma and non-melanoma skin cancer through education by ... a collaboration between the American Academy of Dermatology and Pediatric Sun Protection Foundation, ...
(Date:4/30/2017)... Aliso Viejo, CA (PRWEB) , ... April 30, ... ... liquid animations created exclusively for use in Final Cut Pro X. Editors can ... bursts and more. Easily change the highlights, mid levels and shadows using simple ...
(Date:4/30/2017)... Louis, MO (PRWEB) , ... April 30, 2017 , ... ... a sharp increase in projected attendance for this year’s physician career fairs, with this ... , The complete schedule for the 2017 calendar year of national physician career fairs ...
(Date:4/30/2017)... , ... April 30, 2017 , ... San Francisco Dental ... to announce an updated blog post on the continual issue of the importance of ... seek a second opinion before dental surgery, but this can be a serious mistake. ...
(Date:4/29/2017)... ... April 29, 2017 , ... BECK ... launch of DonorBridge, its process and engagement analytics application built specifically for ... industry expertise with predictive analytics to help nonprofits operate more intelligently and ...
Breaking Medicine News(10 mins):